- Home
- RVPH vs FE Comparison
RVPH vs FE Comparison
Compare RVPH & FE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- FE
- Stock Information
- Founded
- RVPH 2006
- FE 1996
- Country
- RVPH United States
- FE United States
- Employees
- RVPH N/A
- FE N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- FE Electric Utilities: Central
- Sector
- RVPH Health Care
- FE Utilities
- Exchange
- RVPH Nasdaq
- FE Nasdaq
- Market Cap
- RVPH 30.1M
- FE 23.9B
- IPO Year
- RVPH N/A
- FE N/A
- Fundamental
- Price
- RVPH $0.44
- FE $43.80
- Analyst Decision
- RVPH Strong Buy
- FE Buy
- Analyst Count
- RVPH 4
- FE 16
- Target Price
- RVPH $4.75
- FE $46.14
- AVG Volume (30 Days)
- RVPH 2.0M
- FE 3.4M
- Earning Date
- RVPH 11-13-2025
- FE 10-28-2025
- Dividend Yield
- RVPH N/A
- FE 4.06%
- EPS Growth
- RVPH N/A
- FE 49.18
- EPS
- RVPH N/A
- FE 2.27
- Revenue
- RVPH N/A
- FE $13,864,000,000.00
- Revenue This Year
- RVPH N/A
- FE $8.73
- Revenue Next Year
- RVPH N/A
- FE $3.41
- P/E Ratio
- RVPH N/A
- FE $19.30
- Revenue Growth
- RVPH N/A
- FE 6.52
- 52 Week Low
- RVPH $0.30
- FE $37.58
- 52 Week High
- RVPH $4.28
- FE $44.78
- Technical
- Relative Strength Index (RSI)
- RVPH 42.56
- FE 60.88
- Support Level
- RVPH $0.50
- FE $42.87
- Resistance Level
- RVPH $0.48
- FE $43.81
- Average True Range (ATR)
- RVPH 0.03
- FE 0.51
- MACD
- RVPH -0.00
- FE -0.07
- Stochastic Oscillator
- RVPH 2.09
- FE 60.78
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About FE FirstEnergy Corp.
FirstEnergy is an investor-owned holding company with 10 regulated distribution utilities across six mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems.